DP

Pham Thanh Duy; Duy Pham Thanh; Duy Thanh Pham; Duy PT, PT Duy; Duy Pham; Pham T Duy; Duy T Pham

Oxford University Clinical Research Unit

Research areas: Medicine · Microbiology · Salmonella and Campylobacter epidemiology · Antibiotic Resistance in Bacteria · Antibiotic Use and Resistance

ORCID iD 0000-0001-7029-9210

About

I lead the Molecular Epidemiology group at Oxford University Clinical Research Unit (OUCRU) in Vietnam. My group investigates molecular evolution, genomic epidemiology, and clinical impact of drug-resistant bacterial infections in Vietnam and across Asia. Our research is multidisciplinary—combining genomics, molecular biology, epidemiology, and clinical data to elucidate the factors shaping the evolution and transmission of antimicrobial-resistant (AMR) pathogens and their clinical consequences. My long-term vision is to tackle local and regional public health challenges driven by drug-resistant bacteria through locally led, high-quality research.

Since 2008, I have conducted research on typhoid fever (Salmonella Typhi and Paratyphi A) and diarrheal diseases (diarrheagenic E. coli, Shigella, and non-typhoidal Salmonella). More recently, my work has expanded to include community-acquired bloodstream infections (ExPEC and Klebsiella pneumoniae) and hospital-acquired infections (A. baumannii and K. pneumoniae).

My ongoing projects are multidisciplinary and employ cutting-edge approaches. A key Wellcome-funded project investigates the emergence and impact of azithromycin-resistant typhoid fever in South Asia, integrating genomics, transcriptomics, macrophage assays, and evolutionary experiments within a clinical trial framework. Additional projects examine the impact of antibiotic therapy on the human gut microbiome, horizontal plasmid transfer, and the evolution of AMR in children with typhoid fever and dysentery.

My current focus is the genomic epidemiology, ecological dynamics, and evolutionary patterns of hypervirulence and antimicrobial resistance in Klebsiella pneumoniae. In collaboration with the University of Oxford, I am characterizing adaptive immune responses to K. pneumoniae protein candidates in patients with bloodstream infections. I also lead a multi-country Klebsiella pneumoniae genomic surveillance network across Wellcome-funded Major International Programmes in Vietnam, Cambodia, Indonesia, Kenya, Malawi, and South Africa.

Employment

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (100)